tyrosine has been researched along with Drug Withdrawal Symptoms in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Aniello, E; Damaj, MI; Di Marzo, V; Donvito, G; Giordano, C; Guida, F; Ignatowska-Jankowska, BM; Jackson, A; Lichtman, AH; Maione, S; Mechoulam, R; Muldoon, P; Mustafa, MA; Parker, L; Petrie, GN; Piscitelli, F; Sim-Selley, L; Smoum, R; Vitale, RM | 1 |
| de Oliveira, CV; Funck, VR; Furian, AF; Grigoletto, J; Oliveira, MS; Pereira, LM; Rambo, LM; Ribeiro, LR; Royes, LF | 1 |
| Cherniakova, IV; Gudasheva, TA; Klodt, PM; Kolik, LG; Konstantinopol'skiĭ, MA; Kudrin, VS | 1 |
| Bagdas, D; Carroll, FI; Damaj, MI; Greenwald, M; Jackson, A; Lichtman, AH; Miles, MF; Muldoon, PP | 1 |
| Barlocco, F; Caracciolo, M; D'Urbano, M; De Servi, S; Klugmann, S; Mariani, G; Nichelatti, M; Savonitto, S | 1 |
| Epstein, OI; Pan, IR; Titkova, AM | 1 |
| Dylag, T; Kosior, M; Kotlinska, J; Rafalski, P; Silberring, J; Talarek, S | 1 |
| Andrews, JC; Jensen, MD; Moller, N; Nair, KS; Rizza, RA | 1 |
| Bryant, SD; Jinsmaa, Y; Lazarus, LH; Li, T; Marczak, ED; Okada, Y; Tsuda, Y | 1 |
| Herrera, E; Martín del Río, R; Mena, MA | 1 |
| Lapierre, YD; Rastogi, RB; Singhal, RL | 1 |
| Bunney, WE; Kopanda, RT; Murphy, DL | 1 |
| Abu-Murad, C; Littleton, JM | 1 |
| Lewis, MJ; Margules, DL | 1 |
| Chadwick, MJ; Gregory, DL; Wendling, G | 1 |
| Berman, ML; Tennant, F | 1 |
| Borisenko, SA; Burov, IuV | 1 |
| Dackis, CA; Gold, MS | 1 |
| Algeri, S; Costa, E | 1 |
| Greer, MA; Studer, H | 1 |
| Rosenman, SJ; Smith, CB | 1 |
1 review(s) available for tyrosine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Pharmacological approaches to cocaine addiction.
Topics: Brain Chemistry; Bromocriptine; Cocaine; Desipramine; Dopamine; Euphoria; Humans; Receptors, Dopamine; Reward; Substance Withdrawal Syndrome; Substance-Related Disorders; Tyrosine | 1985 |
2 trial(s) available for tyrosine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Loss, Surgical; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug-Eluting Stents; Emergencies; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Perioperative Care; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Substance Withdrawal Syndrome; Ticlopidine; Tirofiban; Tyrosine | 2010 |
A double-blind amino acids, L-tryptophan and L-tyrosine, and placebo study with cocaine-dependent subjects in an inpatient chemical dependency treatment center.
Topics: Adolescent; Adult; Cocaine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; MMPI; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1990 |
18 other study(ies) available for tyrosine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice.
Topics: Animals; Brain Injuries, Traumatic; Cerebral Cortex; Conditioning, Classical; Glycine; Male; Mecamylamine; Mice; Nicotine; Oleic Acids; Oxazoles; PPAR alpha; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine | 2019 |
Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex.
Topics: Animals; Atorvastatin; Cerebral Cortex; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide; Oxidation-Reduction; Pyrroles; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Superoxide Dismutase; Tyrosine | 2013 |
[Neurotensin NT (8- 13) dipeptide analog dilept increases the pain threshold and decreases the severity of morphine withdrawal syndrome in rats].
Topics: Animals; Dopamine; Frontal Lobe; Hypothalamus; Male; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neurotensin; Pain; Pain Threshold; Peptide Fragments; Proline; Rats; Serotonin; Severity of Illness Index; Substance Withdrawal Syndrome; Tyrosine | 2013 |
In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Anesthetics, Local; Animals; Benzamides; Bridged Bicyclo Compounds; Cocaine; Conditioning, Operant; Disease Models, Animal; Fenofibrate; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Oxazoles; PPAR alpha; Pyrimidines; Self Administration; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tyrosine | 2017 |
Effects of potentiated antibodies against brain-specific S100 protein on biogenic amine content and lipid peroxidation in rats under conditions of alcoholization.
Topics: Animals; Antibodies; Biogenic Amines; Brain; Dopamine; Epinephrine; Ethanol; Lipid Peroxidation; Male; Norepinephrine; Rats; S100 Proteins; Substance Withdrawal Syndrome; Tryptophan; Tyrosine | 2003 |
Influence of nociceptin(1-17) fragments and its tyrosine-substituted derivative on morphine-withdrawal signs in rats.
Topics: Animals; Male; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Nociceptin; Opioid Peptides; Peptide Fragments; Rats; Rats, Wistar; Receptors, Opioid; Substance Withdrawal Syndrome; Tyrosine; Vasodilator Agents | 2004 |
Renal amino acid, fat and glucose metabolism in type 1 diabetic and non-diabetic humans: effects of acute insulin withdrawal.
Topics: Amino Acids; Blood Flow Velocity; Diabetes Mellitus, Type 1; Glucose; Humans; Hypoglycemic Agents; Insulin; Kidney; Leucine; Palmitic Acid; Phenylalanine; Reference Values; Renal Circulation; Substance Withdrawal Syndrome; Tyrosine | 2006 |
[N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties.
Topics: Analgesics, Opioid; Animals; Brain; Cell Line; Cell Membrane; Cyclic AMP; Guanosine 5'-O-(3-Thiotriphosphate); Male; Mice; Oligopeptides; Protein Binding; Radioligand Assay; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Tyrosine | 2007 |
The effect of long-term ethanol maternal ingestion and withdrawal on brain regional monoamine and amino acid precursors in 15-day-old rats.
Topics: Alcoholism; Amino Acids; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Female; Humans; Hydroxyindoleacetic Acid; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Rats; Rats, Inbred Strains; Serotonin; Substance Withdrawal Syndrome; Time Factors; Tryptophan; Tyrosine | 1984 |
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Body Weight; Brain; Brain Chemistry; Bromazepam; Cerebral Cortex; Corpus Striatum; Diazepam; Dopamine; Homovanillic Acid; Humans; Hypothalamus; Male; Medulla Oblongata; Mesencephalon; Motor Activity; Norepinephrine; Pons; Rats; Substance Withdrawal Syndrome; Tyrosine | 1977 |
Sleep and behavioral changes possibly reflecting central receptor hypersensitivity following catecholamine synthesis inhibition in man.
Topics: Behavior; Bipolar Disorder; Dopamine; Humans; Levodopa; Norepinephrine; Receptors, Neurotransmitter; Sleep; Substance Withdrawal Syndrome; Tryptophan; Tyrosine | 1977 |
Alteration in serum tyrosine and tryptophan concentrations associated with the induction of physical dependence on ethanol in mice.
Topics: Alcoholism; Animals; Humans; Male; Mice; Substance Withdrawal Syndrome; Tryptophan; Tyrosine | 1978 |
Opioid-reinforced operant behavior: selective suppression by alpha-methyl-para-tyrosine.
Topics: Administration, Oral; Animals; Benzimidazoles; Benzyl Compounds; Catecholamines; Conditioning, Operant; Depression, Chemical; Diethylamines; Dose-Response Relationship, Drug; Extinction, Psychological; Humans; Injections, Intraperitoneal; Isomerism; Male; Methyltyrosines; Milk; Morphine; Morphine Dependence; Motor Activity; Rats; Recurrence; Reinforcement Schedule; Reinforcement, Psychology; Substance Withdrawal Syndrome; Tyrosine; Water Deprivation | 1975 |
Stepwise detoxification from cocaine. A promising regimen.
Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine | 1988 |
[Effect of pharmacological substances on the altered permeability of the hemato-encephalic barrier for 14C-tyrosine due to ethanol].
Topics: Alcoholism; Animals; Blood-Brain Barrier; Carbon Radioisotopes; Cell Membrane Permeability; Chlorpromazine; Dose-Response Relationship, Drug; Ethanol; Haloperidol; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Tyrosine; Vitamin E | 1987 |
Physical dependence on morphine fails to increase serotonin turnover rate in rat brain.
Topics: Animals; Body Temperature; Brain; Carbon Isotopes; Fenclonine; Humans; Male; Mathematics; Morphine Dependence; Nalorphine; Norepinephrine; Rats; Serotonin; Substance Withdrawal Syndrome; Tritium; Tryptophan; Tyrosine | 1971 |
Thyroid function during the rebound phase following the discontinuation of antithyroid drugs.
Topics: Animals; Deficiency Diseases; Diiodotyrosine; Humans; Iodine; Perchlorates; Propylthiouracil; Rats; Substance Withdrawal Syndrome; Thyroid Gland; Thyroxine; Triiodothyronine; Tyrosine | 1967 |
14 C-catecholamine synthesis in mouse brain during morphine withdrawal.
Topics: Animals; Brain; Brain Chemistry; Carbon Isotopes; Dopamine; Drug Tolerance; Female; Humans; Injections, Intraperitoneal; Kinetics; Mice; Morphine; Morphine Dependence; Norepinephrine; Substance Withdrawal Syndrome; Time Factors; Tyrosine | 1972 |